Biotech · Private company
Persevere Therapeutics Inc.
Track this companyFree. Adds Persevere Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- misetionamide (also known as GP-2250)Phase 1 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With GemcitabinePHASE1 · RECRUITING · started Jan 14, 2019ClinicalTrials.gov NCT03854110 · fetched Nov 12, 2026